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Abstract
Background: Travel time and distance are barriers to care for HIV-infected children in rural sub-Saharan Africa.
Decentralization of care is one strategy to scale-up access to antiretroviral therapy (ART), but few programs have been
evaluated. We compared outcomes for children receiving care in mobile and hospital-affiliated HIV clinics in rural Zambia.
Methods: Outcomes were measured within an ongoing cohort study of HIV-infected children seeking care at Macha
Hospital, Zambia from 2007 to 2012. Children in the outreach clinic group received care from the Macha HIV clinic and
transferred to one of three outreach clinics. Children in the hospital-affiliated clinic group received care at Macha HIV clinic
and reported Macha Hospital as the nearest healthcare facility.
Results: Seventy-seven children transferred to the outreach clinics and were included in the analysis. Travel time to the
outreach clinics was significantly shorter and fewer caretakers used public transportation, resulting in lower transportation
costs and fewer obstacles accessing the clinic. Some caretakers and health care providers reported inferior quality of service
provision at the outreach clinics. Sixty-eight children received ART at the outreach clinics and were compared to 41 children
in the hospital-affiliated clinic group. At ART initiation, median age, weight-for-age z-scores (WAZ) and CD4+ T-cell
percentages were similar for children in the hospital-affiliated and outreach clinic groups. Children in both groups
experienced similar increases in WAZ and CD4+ T-cell percentages.
Conclusions: HIV care and treatment can be effectively delivered to HIV-infected children at rural health centers through
mobile ART teams, removing potential barriers to uptake and retention. Outreach teams should be supported to increase
access to HIV care and treatment in rural areas.
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Introduction
In 2012, an estimated 230,000 children were newly infected
with the human immunodeficiency virus (HIV) in sub-Saharan
Africa, bringing the total number of children living with HIV in
the region to 2.9 million [1]. Over the last decade, great progress
has been made in providing these children access to lifesaving
treatment. The number of children receiving antiretroviral
therapy (ART) in sub-Saharan Africa increased from 85,000 in
2006 to 551,065 in 2012 [1,2]. However, progress must continue
so all eligible HIV-infected children have access to treatment as
only 32% of children in need currently receive ART [1].
In much of sub-Saharan Africa, provision of free ART services
has created demands on the health system that are not sustainable
given current levels of infrastructure and human resources. This
increased demand has necessitated a shift away from a medical
model of care, primarily used in resource-rich countries and
relying on highly trained medical personnel in specialized
healthcare facilities to provide individualized HIV care and
treatment, to a public health model that delivers treatment to
more individuals [3]. The public health model relies on
decentralization of HIV services to increase access, particularly
in rural areas, task-shifting of activities to overcome the dearth of
healthcare personnel [4], and standardized and simplified
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regimens and care packages to facilitate administration of care and
treatment to large numbers of patients [5].
Different strategies for decentralizing HIV services have been
developed in sub-Saharan African countries that are adapted to
local conditions, influenced by varying roles of donor support, and
incorporate lessons learned over the past decade. Many programs
have implemented services at primary health centers, with care
and treatment administered by general practitioners, clinical
officers or nurses [6–20]. Several of these programs are assisted by
mobile teams from hospital programs to support ART provision in
primary health centers that do not have the full complement of
facilities and human resources to provide comprehensive HIV
services. Others have implemented home-based [21–23] and
community-based [24] programs, with care and medication
delivered by trained volunteers or field officers. By delivering
care and treatment closer to home, these programs have succeeded
in removing the main structural barriers, including transportation
and distance to the clinic, to initiating and sustaining care [25].
Evaluations of these programs, many of which have been
conducted among adults, have found improved retention and
lower loss to follow-up compared with centralized, hospital-based
care [6–9,17,20].
While decentralization has succeeded in increasing access to
care for large numbers of patients, particularly in rural areas, one
concern is that transitioning from specialized healthcare facilities
and trained healthcare personnel may compromise the quality of
care. Published evaluations of treatment outcomes in decentralized
programs have largely been favorable and several, but not all
[6,16], programs found similar or better survival and clinical and
virologic outcomes compared with hospital-based care [7–
9,17,20–22]. However, additional evaluations are needed of
decentralized programs, particularly for children, to ensure
optimal care and the full benefits of treatment. In rural southern
Zambia, a mobile ART program for children was evaluated and
treatment outcomes were compared among HIV-infected children
receiving care in mobile and hospital-affiliated HIV clinics.
Methods
Ethics statement
The study was approved by the Ministry of Health of the
Government of Zambia, the University of Zambia Biomedical
Research Ethics Committee and the Institutional Review Board of
the Johns Hopkins Bloomberg School of Public Health. Caretakers
provided written informed consent and children 8–16 years of age
provided assent to participate in the study.
ART provision in Zambia
In 2004, the Government of Zambia initiated public sector
ART programs, with roll-out beginning in primary care clinics in
the Lusaka Urban District [26] and subsequently implemented
throughout the country. The program provides ART and basic
laboratory tests, including CD4+ T-cell counts, free of charge. The
number of ART sites increased from four in 2004 to 454 in 2010
[27].
While 61% of the Zambian population resides in rural areas
[28], ART services are primarily offered in urban areas and in
district level hospitals where the infrastructure and human and
technical resources are greatest. To reach those affected by HIV in
rural areas and increase access to HIV services, the Zambian
Ministry of Health introduced the national Mobile ART Services
program in 2007 [29]. Under this program, mobile ART teams of
medical professionals were created at district hospitals. Rural
health centers (RHC) in the catchment area were selected as
designated ART outreach sites to be visited every two weeks by the
mobile ART teams. Rural health center staff provide reproductive,
maternal and child health care, treatment for tuberculosis, HIV
testing, and other basic services, but generally do not have the
training or capacity to provide ART. The mobile ART team
assists staff at the ART outreach site in providing ART services,
builds capacity and coordinates laboratory services. This program
has contributed to the decentralization of ART services to the
primary health care level to maximize limited resources and reach
the greatest number of people in need.
Study setting, clinical care and referral procedures
This study was conducted at the rural HIV clinic at Macha
Hospital in Southern Province, Zambia. The study setting and
population have been described in detail elsewhere [30,31]. In
brief, Macha Hospital serves as a referral hospital for at least 13
rural health centers, providing services for patients within an
80 km radius. The catchment area of Macha Hospital is populated
by traditional villagers living in small, scattered homesteads,
characteristic of much of rural sub-Saharan Africa, with an
estimated population size of over 150,000 persons. The HIV clinic
has provided care to more than 8500 HIV-infected adults and
children since 2005. HIV care services, including antiretroviral
treatment, are provided through the Government of Zambia’s
antiretroviral treatment program, with support from the Presi-
dent’s Emergency Plan for AIDS Relief. The clinic provides care
and treatment free of charge by physicians, clinical officers and
nurses.
Children diagnosed with HIV infection are determined to be
eligible for ART according to guidelines established by the
Ministry of Health [32]. Children eligible for ART must undergo
counseling to ensure the family is prepared to initiate ART. Upon
initiation, children are seen every two weeks for the first month
and every month for the following two months. Thereafter, the
child is seen at three-monthly intervals if adherence and clinical
response are good. Standard ART regimens consist of zidovudine,
stavudine or abacavir plus lamivudine, and nevirapine or
efavirenz.
Due to increasing patient numbers and considerable travel
distance to access HIV services [30], the HIV clinic began a
mobile ART program in 2007. Three rural health centers were
selected as outreach clinics based on distance and size of the
catchment populations, and were located 13 km (Mapanza RHC
in Choma District), 21 km (Chilala RHC in Kalomo District) and
46 km (Moobola RHC in Namwala District) from the hospital. In
2010, Chilala RHC began providing ART services independently
and children who were seen in the outreach clinic were officially
transferred from the Macha HIV clinic. The selected outreach
clinics are staffed with an average of one clinical officer and a
minimum of two nurses.
The outreach team from the Macha Hospital clinic consists of at
least one clinical officer or licentiate, nurse, pharmacy dispenser,
laboratory assistant, counselor and data entry clerk. Medications,
medical consumables and transportation are provided by the
hospital. As laboratory testing cannot be performed at the
outreach clinics, blood samples are collected and transported
from the outreach clinic to the Macha Hospital laboratory, and
results are returned during the next outreach visit. Clinically stable
patients with good adherence are provided with a 3-month supply
of medication.
Children are eligible for referral to the outreach clinic for care
and treatment if they have been stable on ART for at least three
months, demonstrated good adherence, have no opportunistic
infections, and their caregiver requested to receive care closer to
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home. Children not yet eligible for ART and in stable condition
can also be referred to the outreach clinic with the understanding
that referral back to the hospital clinic might be needed once the
child becomes eligible for ART or their condition worsens. Few
children start ART at an outreach clinic.
Study procedures
Beginning in September 2007, HIV-infected children younger
than 16 years of age and registered at the HIV clinic at Macha
Hospital were eligible for enrollment into an observational cohort
study. This report describes a subset of these children receiving
care between September 2007 and March 2012.
Children were evaluated at study visits approximately every
three months. At each visit, a structured questionnaire was
administered to the caregiver to collect information on socio-
demographics, household characteristics, and medical and treat-
ment history. The child was examined to measure height and
weight, and a blood specimen was obtained to measure CD4+ T-
cell counts and percentages (Guava Easy CD4 system; Guava
Technologics, Inc., Hayward, CA) as part of clinical care. Plasma
levels of HIV RNA were quantified by reverse transcriptase
polymerase chain reaction assay (Amplicor HIV-1 Monitor v. 1.5,
Roche Molecular Systems; lower limit of detection of 400 copies/
mL, upper limit of detection 750,000 copies/mL) as part of the
study. Due to financial constraints, viral load testing was not
performed at all study visits; samples for viral load testing were
selected every three months during the first year of ART and every
six months thereafter. Adherence was assessed at every visit by pill
counts and syrup volume measurements. For children who missed
study visits, home visits were attempted to ascertain their status.
Upon implementation of the mobile ART program, some study
children were transferred to outreach clinics and a study assistant
was added to the outreach team to continue study procedures at
outreach visits. A questionnaire was administered to the caretaker
at one outreach clinic visit to obtain information on health care
delivery system related factors, including access to care and
perceived quality of care at the outreach clinic.
Statistical analysis
Two analyses were conducted. The first analysis compared
modes of transportation and travel time before and after transfer
to the outreach clinic and assessed the perceived quality of care at
the outreach clinics. HIV-infected children who transferred to the
outreach clinic and whose caregiver completed a questionnaire
both at study entry and upon transfer to the outreach clinic were
eligible to be included in this analysis.
The second analysis compared treatment outcomes between
children receiving ART who transferred to the outreach clinics
and children receiving ART at the Macha HIV clinic who
reported Macha Hospital as their hospital-affiliated rural health
center. This comparison group was selected as these children live
in the vicinity of the Macha HIV clinic and would not have been
transferred to an outreach clinic, thereby removing potential
confounding by distance to the clinic which is known to impact
clinical outcomes. All children were required to have initiated
ART before September 1, 2011 and have at least one study visit
after ART initiation. Children in the outreach group were
required to have transferred to an outreach clinic before
September 1, 2011 and have at least one study visit after transfer.
Children in both groups remained in the analysis until the first
of death, transfer, loss to follow-up, or administrative censoring on
March 1, 2012. Transfer in this context was defined as transfer of
care to a clinic other than one of the outreach clinics. Children
attending Chilala Clinic when it became independent were
censored on their last study visit. Loss to follow-up was defined
as failure to attend a study visit for at least six months prior to
March 1, 2012.
Descriptive statistics were used to compare the hospital-affiliated
clinic group and outreach groups on characteristics at study entry
and at ART initiation. A measure of socio-economic status (SES)
was calculated based on the Demographic and Health Survey SES
scale used in Zambia [33], with scores ranging from 0 to 24. SES
percentiles were based on the predetermined cutoffs (,25th = 0–6;
26–50th = 7–12; 51–75th = 13–18; .75th = 19–24). Weight-for-age
z-scores (WAZ) among children younger than 10 years of age were
calculated based on the WHO growth standards [34], and
children with z-scores below 22 were defined as underweight.
Severe immunodeficiency was defined by CD4+ T-cell percentage
according to the WHO 2006 treatment guidelines [35]. If
laboratory tests were not available from the visit at which ART
was initiated, results within three months prior to the date of
initiation were used.
Immunologic, clinical and virologic treatment outcomes were
assessed, including CD4+ T-cell percentage, WAZ and viral
suppression. For CD4+ T-cell percentage and WAZ, children were
included if they had at least one measure available after ART
initiation. Both outcomes were evaluated using linear regression
with generalized estimating equations (GEE) with robust variance
estimation to account for repeated measures per child. Models for
each outcome compared: 1) pre-transfer visits in the outreach
group to all visits in the hospital-affiliated clinic group; 2) post-
transfer visits in the outreach group to all visits in the hospital-
affiliated clinic group; and 3) changes between last pre-transfer
visit and the 6-month post-transfer visit in the outreach group to
changes between visits at a similar interval (6 months) in the
hospital-affiliated clinic group. Models included the duration of
ART and other covariates found to differ (p,0.10) between
children in the outreach and hospital-affiliated clinic groups and
known to be causally associated with each outcome. Trajectories
of each outcome were explored using linear mixed effects models
with random intercept, exchangeable correlation structure and
robust standard error estimation. As neither outcome was linear
over time, a spline term was added at 7.5 months, the upper
window around the 6-month measure. The primary exposure in
the models was clinic (hospital-affiliated vs. outreach clinic), which
was treated as a time-varying covariate. Interactions between
clinic and time were included in the models to determine whether
trajectories of the outcomes differed between children in the
hospital-affiliated and outreach clinics.
For virologic outcomes, the proportion of children with viral
suppression, defined as a HIV viral load below the limit of
detection (400 copies/mL), was calculated for each visit after ART
initiation. The proportion of children with viral suppression at
each visit was compared between children in the hospital-affiliated
and outreach clinic groups using chi-square tests. Unadjusted and
adjusted logistic regression models with GEE were used to
compare the odds of detectable viral load between children in
the outreach and hospital-affiliated clinics (treated as a time-
varying covariate) during follow-up. Detectable viral load was
Figure 1. Travel time (A), mode (B), and cost (C) before and after transfer to outreach clinics. Note: participants were able to report more
than one mode of travel to the clinic.
doi:10.1371/journal.pone.0104884.g001
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Table 1. Characteristics of HIV-infected children receiving ART at the hospital-affiliated and outreach clinics.
Hospital-affiliated Clinic (n =41) Outreach Clinics (n=68) p-value
At entry n (%) n (%)
Male 19 (46.3) 37 (54.4) 0.41
Median age in years (IQR) 4.9 (2.2, 9.4) 2.9 (1.6, 7.5) 0.07
Age (years) 0.70
,1 3 (7.3) 7 (10.3)
1–1.9 7 (17.1) 16 (23.5)
2–4.9 11 (26.8) 19 (27.9)
$5 20 (48.8) 26 (38.2)
Status of parents 0.03
Both alive 22 (53.7) 51 (75.0)
One parent alive 15 (36.6) 10 (14.7)
Both parents died 4 (9.8) 7 (10.3)
Other household member receiving ART 21 (52.5) 43 (64.2) 0.23
SES quartile 0.21
1st (lowest) 28 (68.3) 41 (60.3)
2nd 10 (24.4) 26 (38.2)
3rd 2 (4.9) 1 (1.5)
4th (highest) 1 (2.4) 0 (0.0)
Education of primary caregivera 0.20
None 0 (0.0) 2 (3.1)
Primary 19 (55.9) 43 (67.2)
Secondary 14 (41.2) 19 (29.7)
College/technical training 1 (2.9) 0 (0.0)
Travel time (hours)b 0.53
,1 19 (46.3) 15 (31.9)
1–2 15 (36.6) 21 (44.7)
3–4 5 (12.2) 9 (19.2)
$5 2 (4.9) 2 (4.2)
At ART initiation
Median age in years (IQR) 5.9 (2.4, 10.4) 2.9 (1.7, 7.3) 0.03
Age (years) 0.15
,1 3 (7.3) 6 (8.8)
1–1.9 4 (9.8) 17 (25.0)
2–4.9 11 (26.8) 20 (29.4)
$5 23 (56.1) 25 (36.8)
Median WAZ (IQR) 21.7 (22.5, 20.7) 22.3 (23.6, 21.3) 0.07
Underweight 12 (41.4) 34 (58.6) 0.13
Median CD4% (IQR) 14.4 (11.0, 19.5) 14.2 (10.5, 18.9) 0.91
Severe immunosuppression 23 (62.2) 36 (65.5) 0.75
ART regimen 0.31
AZT/3TC/EFV 10 (25.0) 15 (22.4)
AZT/3TC/NVP 3 (7.5) 15 (22.4)
D4T/3TC/EFV 16 (40.0) 24 (35.8)
D4T/3TC/NVP 16 (40.0) 24 (35.8)
Other 3 (7.5) 2 (3.0)
3TC: lamivudine; ART: Antiretroviral therapy; AZT: zidovudine; D4T: stavudine; EFV: efavirenz; IQR: interquartile range; NVP: nevirapine; WAZ: weight-for-age z-score;
aamong respondents who were primary caregivers, n = 98.
bafter transfer to the outreach clinic among the outreach clinic group.
doi:10.1371/journal.pone.0104884.t001
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assessed at three thresholds: .400, .1000 and .10,000 copies/
mL.
Adherence during follow-up was also assessed. Caregivers were
instructed to bring all unused medications to each clinic visit and
adherence was measured by pill count or measurement of liquids
for each drug prescribed. Adherence measures were capped at
100%. For children taking individual drugs, the adherence
percentage of the drug to which the patient was least adherent
was used. Optimal adherence was defined as taking more than
95% of drugs prescribed. The proportions of children with optimal
adherence at each visit and at all visits were compared between
children in the hospital-affiliated and outreach clinics using chi-
square tests. Unadjusted and adjusted logistic regression models
with GEE were used to compare the odds of optimal adherence
between children in the outreach and hospital-affiliated clinics
(treated as a time-varying covariate) during follow-up.
All analyses were conducted using SAS for Windows version 9.1
(SAS Institute Inc., Cary, NC) and Stata, version 9 (StataCorp LP,
College Station, TX).
Results
Comparison of HIV-infected children receiving care at the
outreach clinics before and after transfer
A total of 111 HIV-infected children were referred to one of the
outreach clinics before September 1, 2011, and caretakers of 77
(69%) children completed the outreach questionnaire. The median
age of the children at study entry was 3.4 years (IQR: 1.7, 7.7) and
47% were male. Almost all caretakers (99%) reported that it was
easier to get to the outreach clinic compared to Macha Hospital
because they did not have to travel as far (100%), had lower travel
costs (56%), and transportation to the outreach clinic was easier
(67%). After transfer to the outreach clinic, travel time was
significantly shorter (p,0.0001). The proportion of children
travelling more than five hours to get to the clinic decreased from
29% to 4% (figure 1). The proportion of children requiring public
transport, as opposed to walking or using a bicycle, decreased from
39% to 4% (p,0.0001). Consequently, caretakers reported lower
transportation costs and had fewer difficulties in finding transpor-
tation after transferring to the outreach clinic (91% vs. 21%; p,
0.0001). The proportion of caretakers reporting no costs associated
with travel increased from 61% to 96% (p,0.0001).
The majority of caretakers (83%) reported the overall quality of
care at the outreach clinics to be the same as the hospital. When
asked about specific components of care, however, many reported
differences at the outreach clinics. Most caretakers reported the
waiting time to be shorter (85%), but some reported the counseling
services (34%) and physical examination (26%) in the outreach
clinics to be of lower quality than at the hospital clinic.
Comparison of HIV-infected children receiving ART at the
hospital-affiliated and outreach clinics
Characteristics of the population at study entry and ART
initiation. Forty-one children in the hospital-affiliated clinic
group and 68 children in the outreach clinic group received ART
during the study period, of whom 34 and 48, respectively, initiated
Figure 2. Lowess graph of weight-for-age z-score by time since ART initiation for HIV-infected children at the hospital-affiliated
and outreach clinics. Note: Care at outreach clinics was treated as a time-varying covariate.
doi:10.1371/journal.pone.0104884.g002
Mobile and Hospital-Affiliated HIV Care for Children in Rural Zambia
PLOS ONE | www.plosone.org 6 August 2014 | Volume 9 | Issue 8 | e104884
Figure 3. Lowess graph of CD4+ T-cell percentage by time since ART initiation for HIV-infected children at hospital-affiliated and
outreach clinics. Note: Care at outreach clinics was treated as a time-varying covariate.
doi:10.1371/journal.pone.0104884.g003
Table 2. Differences in mean weight-for-age z-scores and CD4+ T-cell percentage between children receiving ART at the hospital-
affiliated and outreach clinics.
Comparison of the outreach clinic group to the hospital-affiliated clinic group Estimate (95% CI)a,b p-valuea
WAZ
1 Outreach: all visits before transfer
Hospital-affiliated: all visits 20.2 (20.7, 0.3) 0.48
2 Outreach: all visits after transfer
Hospital-affiliated: all visits 0.01 (20.5, 0.5) 0.96
3 Outreach: Difference between visit 6 month after transfer and last visit before transfer
Hospital-affiliated: Difference between visits at 6 months intervals 0.4 (20.07, 0.8) 0.10
CD4%
1 Outreach: all visits before transfer
Hospital-affiliated: all visits 21.0 (24.2, 2.2) 0.55
2 Outreach: all visits after transfer
Hospital-affiliated: all visits 23.3 (26.8, 0.2) 0.06
3 Outreach: Difference between visit 6 month after transfer and last visit before transfer
Hospital-affiliated: Difference between visits at 6 month intervals 21.4 (24.5, 1.7) 0.37
CI: Confidence interval; WAZ: weight-for-age z-score.
aEstimates and p-values for comparisons from linear regression with GEE to account for repeated measures per child.
bAdjusted for month on ART, age at ART initiation, underweight at ART initiation and severe immunosuppression at ART initiation.
doi:10.1371/journal.pone.0104884.t002
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ART during the study period. Children in the outreach clinic
group were similar to the hospital-affiliated clinic group at study
entry, except they were more likely to be younger (median age: 2.9
vs. 4.9 years; p = 0.07) and have both parents alive (75% vs. 54%;
p= 0.03) (Table 1). At ART initiation, children in the outreach
clinic group were more likely to be younger (median age: 2.9 vs.
5.9 years; p = 0.03) and to have a lower WAZ (median WAZ:22.3
vs. 21.7; p = 0.07) (Table 1).
Clinical, immunological and virological responses to
treatment. Children in the outreach and hospital-affiliated
clinic groups were followed for a median of 32.3 (IQR: 22.3, 38.8)
and 33.5 (IQR: 23.1, 42.6) months in the study while receiving
ART (p= 0.50). Among children in the outreach clinic group, the
median time between study enrolment and transfer to the outreach
clinic was 9.1 months (IQR: 3.9, 14.4), and children received care
at the outreach clinic for a median of 23.8 months (IQR: 12.2,
32.4) during the study. Two children started ART at the outreach
clinic.
Children in both groups responded well to ART (Figures 2 and
3). Mean WAZ did not differ between the outreach and hospital-
affiliated clinic groups either before (difference: 20.2; 95%
confidence interval [CI]: 20.7, 0.3; p = 0.48) or after transfer
(difference: 0.01; 95% CI: 20.5, 0.5; p = 0.96), after adjusting for
month on ART and age, underweight, and severe immunosup-
pression at ART initiation (Table 2). Changes in WAZ among
children in the outreach group between the last visit at the
hospital-affiliated clinic and 6 months after transfer also did not
differ significantly from changes in WAZ among children in the
hospital-affiliated clinic group over the same time interval
(Table 2). These findings are supported by longitudinal models
comparing trajectories between the two groups (Table S1).
Mean CD4+ T-cell percentage did not differ between the
outreach and hospital-affiliated clinic groups before transfer
(difference: 21.0; 95% CI: 24.2, 2.2; p= 0.55) and was non-
significantly lower in the outreach group after transfer (difference:
23.3; 95% CI: 26.8, 0.2; p = 0.06), after adjusting for month on
ART and age, underweight, and severe immunosuppression at
ART initiation (Table 2). Changes in CD4+ T-cell percentage
among children in the outreach group between the last visit at the
hospital-affiliated clinic and 6 months after transfer did not differ
significantly from changes in CD4+ T-cell percentage among
children in the hospital-affiliated clinic group over the same time
interval (Table 2). These findings are supported by longitudinal
models comparing trajectories between the two groups (Table S1).
Viral suppression was assessed up to three years after ART
initiation. The proportion of children with undetectable viral load
was lower among children receiving care at the outreach clinics at
each time point, although samples sizes were small and few
differences were statistically significant (Table 3). Considering all
measures during follow-up (n= 473), viral load measures from
children in the outreach clinics were significantly more likely to be
detectable at .400 copies/mL (17% vs. 8%; p= 0.002), .1000
copies/mL (16% vs. 7%; p= 0.002) and.10,000 copies/mL (10%
vs. 3%; p= 0.001) than from children in the hospital-affiliated
clinic. In a crude model, the odds of viral load .400 copies/mL
(odds ratio [OR]: 1.62; 95% CI: 0.75, 3.50), viral load .1000
copies/mL (OR: 1.59; 95% CI: 0.67, 3.79), and viral load .
10,000 copies/mL (OR: 2.50; 95% CI: 0.87, 7.18) were higher for
children in the outreach clinics compared to children in the
hospital-affiliated clinic, although these results were not statistically
significant. Adjusting for age and underweight at ART initiation
and month of ART did not significantly affect the results (.400
copies/mL: OR: 1.52, 95%: 0.56, 4.10; .1000 copies/mL: OR:
1.85, 95% CI: 0.72, 4.76; .10,000 copies/mL: 5.14, 95% CI:
1.50, 17.61).
Adherence. The proportion of children with optimal adher-
ence (.95%) at each study visit tended to be lower for those
receiving care at the outreach clinics compared to the hospital-
affiliated clinic, although no significant differences were observed
(Table S2). In a crude model, the odds of optimal adherence were
non-significantly lower for children in the outreach clinics
compared to the hospital-affiliated clinic (odds ratio [OR]: 0.71;
95% confidence interval [CI]: 0.45, 1.12). Adjusting for age and
underweight at ART initiation and month of ART did not
significantly impact the estimate (OR: 0.69; 95% CI: 0.41, 1.15).
To further investigate adherence, all visits after ART initiation
(combining visits at the hospital-affiliated and outreach clinics for
children in the outreach clinic group) were considered. Children
receiving care at the outreach clinic had poorer adherence, with
the median percentage of visits with optimal adherence (69.2% vs.
79.3%; p= 0.01) and the proportion of children with optimal
adherence at all study visits (24.6% vs. 32.5%; p= 0.35) lower in
the outreach compared to the hospital-affiliated clinic group.
When adherence among children in the outreach clinic group was
stratified by location, no significant difference in adherence was
found before and after transfer to the outreach clinics. The median
percentage of visits with optimal adherence was 75% (IQR: 50,
100) before and 75% (IQR: 43, 100) after transfer (p = 0.81). The
Table 3. Plasma HIV viral loads over time among children receiving ART at hospital-affiliated and outreach clinics.
Hospital-affiliated Clinic Outreach Clinicsa
Month on ART N % undetectable VL N % undetectable VL p-value
3 44 90.9 3 100.0 0.59
6 61 90.2 6 100.0 0.42
9 34 94.1 8 50.0 0.001
12 52 94.2 24 87.5 0.31
18 28 100.0 29 82.8 0.02
24 30 90.0 26 76.9 0.18
30 12 91.7 16 81.3 0.44
36 11 81.8 13 76.9 0.77
ART: antiretroviral therapy; VL: viral load.
aOutreach treated as a time-varying covariate.
doi:10.1371/journal.pone.0104884.t003
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proportion of children with optimal adherence at all visits before
and after transfer was 39% and 34% (p= 0.59), respectively.
Retention in care. At the end of the study, after a median of
34 months on treatment, 75% of children in the outreach clinic
group and 95% of children in the hospital-affiliated clinic group
were active in the program. Among children followed at the
hospital-affiliated clinic, none died or were lost to follow-up and
two children (4.9%) were transferred to other clinics. Among
children followed at the outreach clinics, one died from drowning
(1.5%) and none were lost to follow-up. The primary reason for
departure from the program in the outreach clinic group was
transfer: four children (5.9%) were transferred to other clinics and
12 children (17.6%) were transferred to Chilala Clinic when it
became an independent ART clinic.
Discussion
Decentralization from higher to lower level health facilities and
task-shifting from higher to lower level care providers are essential
if access to HIV care is to increase in resource-limited countries in
the face of rising patient numbers [7]. Bringing care closer to
patients can provide benefits beyond simply being able to treat
more people. Reducing the travel distance and time required for
patients to access clinics can improve retention in care, adherence
to ART, and quality of life. In addition, increasing the number of
healthcare facilities providing services can reduce the patient load
at all facilities, thereby decreasing waiting times and increasing the
amount of time that healthcare providers can spend with each
patient. All of these factors have the potential to positively impact
treatment outcomes.
Distance to the clinic and transportation were barriers to
retention in care in rural southern Zambia and elsewhere [25,30],
with levels of attrition increasing with travel distance [36]. One
multisite analysis in western, eastern and southern Africa found
that the risk of attrition doubled if travel time to clinic exceeded 2
hours [25]. Distance to the clinic has also been found to be
associated with an increased risk of virologic failure [31]. As HIV
care is lifelong, making services more accessible and providing care
in a familiar environment increases health-related quality of life
and satisfaction with clinical services [37,38], thus increasing the
likelihood of retention in care. Several decentralized HIV
treatment programs reported similar or better outcomes in HIV-
infected adults [7–9,21,22,38] compared with those treated at
hospital-based HIV clinics. A recent study in five countries in sub-
Saharan Africa also reported significantly lower rates of loss to
follow-up (adjusted rate ratio: 0.55) and mortality (adjusted rate
ratio: 0.66) among children cared for at primary health centers
compared to secondary or tertiary health centers [17]. In this
evaluation of mobile and hospital-affiliated HIV care for children
in rural southern Zambia, transfer to the outreach clinic succeeded
in significantly decreasing travel time and costs, barriers accessing
the clinic, and reported waiting times at the clinic. Children
receiving ART at the outreach clinics were able to achieve and
maintain similar clinical and immunological responses to treat-
ment compared to children receiving care at the hospital-affiliated
clinic.
While there are many benefits to decentralization, challenges
remain. Some studies have reported higher mortality among HIV-
infected adults and children cared for at health centers compared
to hospital clinics [6], and higher percentages of adults with
detectable viral load among those followed in primary health
clinics [16]. In this study, children in the outreach group tended to
have lower levels of viral suppression. This may have been due to
the lower observed adherence, which was observed while these
children received care in the hospital-affiliated clinic and persisted
after transfer to the outreach clinics. Reasons for lower adherence
were not determined but may be due to several factors, including
non-disclosure and disrupted routines (e.g., changes in address and
school schedules) [39]. Adequate resources will need to be
available at outreach clinics to monitor adherence and manage
treatment failure. Discussions with the outreach team indicated
that services could be improved at the outreach clinics with
additional staff, particularly counselors, and space dedicated for
clinical exams and counseling sessions. This was also reflected in
perceptions by caregivers that these aspects of care were of lower
quality. Involving community volunteers, including members of
surrounding communities who are HIV-infected, peer educators
or adherence support workers to improve adherence counseling
[40,41] may provide the necessary support for outreach teams to
ensure that HIV-infected patients are adequately monitored.
There were several limitations that should be considered in
interpreting the study results. First, this was an observational study
in which children were transferred to the outreach clinics at
various times after starting treatment at the request of the
caregiver. Only children who responded well to treatment were
eligible for transfer and therefore the outreach clinic group
represented a select group of children. As a valid comparison
group, children of caretakers who named Macha Hospital as their
rural health center were selected to remove the effect of travel
distance. Children in both groups were similar on many
characteristics and measured differences were adjusted for in the
analysis. However, unmeasured differences between the groups
may have remained. Second, the sample size was small,
particularly at longer follow-up times and for virologic outcomes.
Lastly, this study was conducted at one hospital-affiliated clinic
and three outreach clinics in a rural area in Zambia. The
generalizability of the results to other settings may be limited.
Conclusions
This is one of the few studies of HIV-infected children
conducted in rural sub-Saharan Africa comparing treatment
outcomes between different service delivery approaches. HIV care
and treatment can be effectively delivered to HIV-infected
children at rural health centers through mobile ART teams,
removing potential barriers to uptake and retention. Outreach
teams should be supported to continue to increase access to HIV
services in rural areas and ensure that HIV-infected children
receive optimal care and treatment.
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